Can surgeons improve survival in stage IV melanoma?

Journal Article (Journal Article;Review)

Successful systemic management of stage IV melanoma continues to be elusive because of the paucity of effective therapies. This has fueled the continued interest in surgical resection. Several single-institution studies and a current, large, multi-institutional phase III trial have demonstrated a survival benefit for patients who underwent surgical resection for melanoma metastases. Incorporating these results into new approaches using multimodality treatment may enhance survival in patients with stage IV melanoma.

Full Text

Duke Authors

Cited Authors

  • Mosca, PJ; Teicher, E; Nair, SP; Pockaj, BA

Published Date

  • April 1, 2008

Published In

Volume / Issue

  • 97 / 5

Start / End Page

  • 462 - 468

PubMed ID

  • 18270974

International Standard Serial Number (ISSN)

  • 0022-4790

Digital Object Identifier (DOI)

  • 10.1002/jso.20950

Language

  • eng

Conference Location

  • United States